Early stage investors in Chengdu, China
Updated 16 Nov 2026
Venture funds
2 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Chengdu High-tech Ceyuan Capital Chengdu High-tech Ceyuan Capital invests in Chinese technology companies such as Aerofugia and Kunteng Tech. Chengdu, China |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 46% | 3 |
| 2 | Si Chuan Venture Capital Si Chuan Venture Capital is a fund management and investment firm, with recent investments in Hyperway Pharm and Ghostcloud. Chengdu, China |
Health care, Biotech | Early stage venture | 29% | 2 |
Table 1. Early stage investors in Chengdu, China: venture capital and micro VC funds ranked by companies whose Series A and B round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| Rising Investments | Venture capital firm | Chengdu, China | •••@cddxlz.com | 028-61••• |
| Yizhan Capital | Venture capital firm | Chengdu, China | •••@yizhancapital.com | 028 87••• |
| Yunshi Capital | Private equity firm | Chengdu, China | •••@yunzb.cn | 028-83••• |
| Chengdu Technology Transfer Group | Venture capital firm | Chengdu, China | •••@cttg.com.cn | 028-62••• |
| ULTIMA | Private equity firm | Chengdu, China | •••@ultimacap.com | 028-65••• |
| Huaxi Jinzhi Investment | Private equity firm | Chengdu, China | •••@hx168.com.cn | 028-86••• |
6 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 6 of the 23 early stage investors in Chengdu, China have a published email address, 10 a phone number and 17 a website.
- Chengdu Science and Technology Venture Capital has the most recorded investments, 67, 24 of them as lead investor.
- 5 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Chengdu High-tech Ceyuan Capital is an investor in 6 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Hyperway Pharm's $14.9M Series B on 15 October 2026.
- Software is the most common sector across their 45 portfolio companies (38%).
- Seed is the most common investment stage, recorded for 7 of them (30%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Early stage investors in Chengdu, China
17 of 23, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Chengdu Science and Technology Venture Capital | Venture capital firm | Chengdu, China | Biotech, Health care | Kunteng Tech, QL Biopharma, New Radiomedicine Technology | 3 | 67 | 24 | 1 | |||
| 2 | Chengdu High-tech Ceyuan Capital | Venture capital firm | Chengdu, China | Health care, Biotech | Kunteng Tech, Hyperway Pharm, Chuangzhi Lianheng | 6 | 39 | 18 | 2 | (028) ••• | ||
| 3 | Rising Investments | Venture capital firm | Chengdu, China | Hardware, Energy | Aerospace Kate, Ultron Photonics, SimChip Technology | 34 | 12 | 2 | •••@cddxlz.com | 028-61••• | ||
| 4 | Beyond Capital | Private equity firm, Venture capital firm | Chengdu, China | Hardware | AOSSCI | 1 | 30 | 5 | 1 | 028-85••• | In the CSV | |
| 5 | Si Chuan Venture Capital | Venture capital firm | Chengdu, China | Health care, Biotech | Hyperway Pharm, Ghostcloud, Zenitar | 3 | 24 | 7 | 0 | 86-123••• | ||
| 6 | CDHTI Venture Capital | Venture capital firm | Chengdu, China | Hardware, Health care | First Technology, Vantron, Maimai | 17 | 0 | 6 | In the CSV | |||
| 7 | Yizhan Capital | Venture capital firm | Chengdu, China | Hardware | Chengdu Maike, Taco Optoelectronics, Lixin Huigan | 14 | 1 | 0 | •••@yizhancapital.com | 028 87••• | ||
| 8 | Yunshi Capital | Private equity firm | Chengdu, China | Hardware, Artificial intelligence | IceWhale Technology, Pinzhou Technology, Meilin | 11 | 4 | 1 | •••@yunzb.cn | 028-83••• | ||
| 9 | Chengdu Hi-tech Investment Group | Chengdu, China | 10 | 2 | 1 | +86-28••• | In the CSV | |||||
| 10 | Chengdu Technology Transfer Group | Venture capital firm | Chengdu, China | 9 | 4 | 1 | •••@cttg.com.cn | 028-62••• | ||||
| 11 | Chuangshi Ziben | Venture capital firm | Chengdu, China | Fintech, Energy | SAI.TECH, Lian Tianxia | 7 | 1 | 2 | ||||
| 12 | ULTIMA | Private equity firm | Chengdu, China | Hardware, Health care | Maimai, VRDREAMS | 7 | 0 | 0 | •••@ultimacap.com | 028-65••• | In the CSV | |
| 13 | Huaxi Jinzhi Investment | Private equity firm | Chengdu, China | 6 | 3 | 0 | •••@hx168.com.cn | 028-86••• | ||||
| 14 | Shenzhen Qianhai Beizeng Asset Management | Private equity firm | Chengdu, China | 6 | 3 | 0 | ||||||
| 15 | SECCO Investment | Venture capital firm | Chengdu, China | Hardware | Giant Micro Integrated Circuit, Yunchuang Zhixing | 3 | 3 | 0 | ||||
| 16 | Chengdu Industrial Investment | Corporate venture arm, Venture capital firm | Chengdu, China | 3 | 0 | 0 | ||||||
| 17 | Sichuan Provincial Investment Group | Venture capital firm | Chengdu, China | 2 | 1 | 0 | In the CSV |
Table 2. Early stage investors in Chengdu, China: the first 17 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 23.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Chengdu High-tech Ceyuan Capital | Chengdu, China | 6 | 6 | Kunteng Tech, Hyperway Pharm, Chuangzhi Lianheng |
| 2 | Chengdu Science and Technology Venture Capital | Chengdu, China | 3 | 6 | Kunteng Tech, QL Biopharma, New Radiomedicine Technology |
| 3 | Si Chuan Venture Capital | Chengdu, China | 3 | 7 | Hyperway Pharm, Ghostcloud, Zenitar |
| 4 | Guosheng Capital | Chengdu, China | 2 | 2 | Lingtai Krypton Biotechnology, Novamab |
| 5 | Beyond Capital | Chengdu, China | 1 | 2 | AOSSCI |
Table 3. Early stage investors in Chengdu, China: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Hyperway Pharm | Hyperway Pharm conducts pharmaceutical research, development, and production. | Health care | Chengdu, China | Series B | $14.9M | 2026-10-15 | $56.8M | Chengdu High-tech Ceyuan Capital, Si Chuan Venture Capital | 51 to 100 | 2019 |
| QL Biopharma | QL Biopharma develops recombinant protein drugs to treat chronic metabolic diseases. | Biotech | Beijing, China | Series C | $44.7M | 2026-09-14 | $173.7M | Chengdu Science and Technology Venture Capital | 101 to 250 | 2018 |
| Lingtai Krypton Biotechnology | Lingtai Krypton Biotechnology develops lncRNA drugs to treat human diseases. | Biotech | Shuangliu, China | Series A | $13.7M | 2026-06-26 | $13.7M | Guosheng Capital | 11 to 50 | 2021 |
| Yuntian Imagination | Yuntian Imagination provides interactive video cloud services with ultra-high-definition quality and low-latency streaming. | Software | Shenzhen, China | Series E | $148.0M | 2026-06-17 | $248.0M | Chengdu High-tech Ceyuan Capital | 101 to 250 | 2020 |
| Ghostcloud | Ghostcloud is a Kubernetes Certified Service Provider. | Software | Chengdu, China | Series B | $14.7M | 2026-05-08 | $17.7M | Si Chuan Venture Capital | 51 to 100 | 2015 |
| Novamab | Novamab researches and develops new nanobodies. | Biotech | Shanghai, China | Series B | $43.9M | 2026-04-24 | $97.8M | Guosheng Capital | 51 to 100 | 2017 |
| New Radiomedicine Technology | New Radiomedicine Technology supplies medical isotopes in China. | Biotech | Chengdu, China | Series E | $145.4M | 2026-04-03 | $330.6M | Chengdu Science and Technology Venture Capital | 101 to 250 | 2016 |
| Zenitar | Zenitar conducts drug research and biomedical technology industrialization. | Biotech | Chengdu, China | Series C | $86.0M | 2026-01-12 | $155.7M | Chengdu High-tech Ceyuan Capital, Si Chuan Venture Capital | 51 to 100 | 2019 |
Table 4. Early stage investors in Chengdu, China: the 8 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 17 | 38% |
| Hardware | 15 | 33% |
| Health care | 10 | 22% |
| Biotech | 6 | 13% |
| Energy | 4 | 9% |
| Fintech | 3 | 7% |
| Artificial intelligence | 3 | 7% |
| Education | 2 | 4% |
Table 5. Early stage investors in Chengdu, China: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 23 | 100% |
| Seed investors | 7 | 30% |
| Late stage investors | 4 | 17% |
| Venture investors | 4 | 17% |
| Private equity investors | 2 | 9% |
Table 6. Early stage investors in Chengdu, China by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 3 | 17% |
| 2010s | 9 | 50% |
| 2000s | 4 | 22% |
| 1990s | 1 | 6% |
| 1980s | 1 | 6% |
Table 7. Early stage investors in Chengdu, China by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its recorded investment stages include early stage investors and its headquarters is in Chengdu, China. On 16 November 2026 that is 23 investors.
- 6 rows carry an email address and 10 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 17 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 23 rows: 6 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many early stage investors in Chengdu, China are on the list?
- 23, in the file dated 16 November 2026. 5 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 6 of the 23 carry an email address in the download and 10 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 23 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 23 rows, 6 firm email addresses and 10 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 0 of the 6 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.